Try our Advanced Search for more refined results
Competition
Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.
Sign up for a 7-day FREE trial today!
Latest News in Competition
-
November 26, 2025
Health Plans Defend Renewed Biogen MS Drug Scheme Suit
Health plans claiming Biogen Inc. illegally stifled competition for its multiple sclerosis drug Tecfidera have said an Illinois federal judge should let their latest complaint proceed to discovery because it fixes earlier pleading deficiencies and better outlines the drugmaker's allegedly anticompetitive scheme.
-
November 26, 2025
USPTO, DOJ Tell ITC To Limit Exceptions In Netlist Case
The U.S. Patent and Trademark Office has joined the U.S. Department of Justice's Antitrust Division to urge the U.S. International Trade Commission to keep exceptions to its exclusion orders narrow, making the statement in Netlist's case accusing Google and Samsung of infringing its computer memory technology patents.
-
November 26, 2025
Swimmers Defend $1.16M Fee In Antitrust Fight With Aquatics
Swimmers suing World Aquatics over alleged antitrust violations say the objection to an additional $1.16 million in attorney fees is "absurd," arguing the international governing body knows payment would come from a fund separate from the already negotiated attorney fees.
-
November 26, 2025
Anti-Disinformation Nonprofit Claims FTC Retaliation In Suit
An anti-disinformation nonprofit is suing the Federal Trade Commission over a civil investigation demand it claims was sent in retribution for the group's 2022 media market review that listed conservative outlets like The Daily Wire and The Federalist among its top disinformation-risk sites.
-
November 26, 2025
GTCR Drops FTC Constitutional Challenge Over Merger Case
GTCR BC Holdings LLC has agreed to dismiss its constitutional claims against the Federal Trade Commission after enforcers dropped their case challenging the private equity firm's $627 million purchase of medical device coatings company Surmodics Inc.
Areas of Coverage
- AGENCIES
- U.S. Department of Justice, Antitrust Division
- Federal Trade Commission, Bureau of Competition
- European Commission, Competition Directorate
- UK Competition and Markets Authority
- Germany’s Federal Cartel Office
- China’s Ministry Of Commerce
- Japan Fair Trade Commission
- Korea Fair Trade Commission
- Canada’s Competition Bureau
- Brazil’s Council for Economic Defense
- POLICY & REGULATION
- Clayton Act
- Federal Trade Commission Act
- Foreign Corrupt Practices Act
- Racketeer Influenced and Corrupt Organizations Act
- Robinson-Patman Act
- Sherman Act
- International antitrust legislation and regulation
- ENFORCEMENT
- Criminal charges over antitrust issues
- Global cartel investigations and actions
- Merger reviews and second requests
- Merger challenges and divestiture orders
- Anti-monopoly actions
- Pharmaceutical pay-for-delay challenges
- Bid-rigging probes
- Kickback, bribery, and corruption cases
- Challenges to state aid and other subsidies
- LITIGATION
- Antitrust class actions
- Price-fixing cases
- Illegal monopoly suits
- PROFILES
- Personnel moves
- Profiles of competition practices
Readership
- Antitrust and competition lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals